Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXMC5I
|
||||
Drug Name |
4-Cyano-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-1-carboxylic acid (3-bromo-4-cyano-benzyl)-(3-methyl-3H-imidazol-4-ylmethyl)-amide
|
||||
Synonyms |
CHEMBL29503
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C30H25BrN6O
|
||||
Canonical SMILES |
Cn1cncc1CN(Cc2ccc(C#N)c(Br)c2)C(=O)N3CCC(=C(C3)c4cccc5ccccc45)C#N
|
||||
InChI |
InChI=1S/C30H25BrN6O/c1-35-20-34-16-25(35)18-37(17-21-9-10-24(15-33)29(31)13-21)30(38)36-12-11-23(14-32)28(19-36)27-8-4-6-22-5-2-3-7-26(22)27/h2-10,13,16,20H,11-12,17-19H2,1H3
|
||||
InChIKey |
XCKIUXVZLPDAPE-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.